Abstract
Plasma ET-1 was measured around the clock on different calendar dates in healthy subjects and in subjects with diabetes and/or with high blood pressure and/or a history of vascular complications (HVDR). A transverse approach, with each subject contributing a single 24 h mean, assessed any about weekly or half weekly variation in ET-1. A circasemiseptan component resolved by single cosinor for nondiabetic (but not for diabetic) HVDR subjects (p < 0.010) differs on its timing of overall high values (p < 0.050) from that found in healthy subjects (p < 0.006). The results are aligned with circasemiseptan patterns in other circulatory variables and morbidity/mortality statistics.
Original language | English (US) |
---|---|
Pages (from-to) | 1237-1241 |
Number of pages | 5 |
Journal | Peptides |
Volume | 18 |
Issue number | 8 |
DOIs | |
State | Published - 1997 |
Keywords
- Circasemiseptan
- ET-1
- Vascular disease risk